HOME
ABOUT WEX PHARMA
CONTACT US
About Us
Corporate Profile
Management
Contact
Products
About TTX
TTX for Cancer-Related Pain
TTX for Chemotherapy-Induced Neuropathic Pain
Scientific Publications
Clinical Trials
About TTX
TTX Clinical Experience
About Pain
Cancer-Related Pain
Chemotherapy-Induced Neuropathic Pain
The Drug Development Process
TTX Trials
TEC-006
TTX-CINP-201
Physician Resources
Partnering
Opportunities
Partnering Contact
CONTACT US:
WEX Pharmaceuticals Inc.
Telephone:
604-683-8880
Fax: 604-683-8868
Toll Free Canada/USA:
1-800-722-7549
E-Mail: wex@wexpharma.com
CLINICAL TRIALS
Dedicated to the Discovery, Development, Manufacture, and Commercialization of innovative drug products to treat local and systemic pain.
TEC-006 - A clinical trial for the treatment of moderate to severe inadequately controlled cancer-related pain.
TTX-CINP-201 - A clinical trial for the treatment of moderate to severe neuropathic pain caused by chemotherapy in patients with cancer.
MEMBER OF:
CK Life Sciences Int'l.,(Holdings) Inc. (0775.HK) is engaged in research, development and commercialisation of innovative biotechnology products applicable to human health and environmental sustainability.
Copyright WEX Phamaceuticals Inc. All Rights Reserved.
Privacy Policy
Disclaimer